Table 4.
BAL Inflammatory Cells and Cytokines | 0 ppb O3 | 100 ppb O3 | 200 ppb O3 |
---|---|---|---|
BAL, ×104 cells/ml | |||
Total leukocytes | 20.6 ± 11.5 | 21.5 ± 10.6 | 22.6 ± 8.8 |
Macrophages | 17.3 ± 10.0 | 17.6 ± 10.0 | 18.1 ± 6.9 |
Neutrophils | 0.55 ± 0.56* | 0.94 ± 0.91* | 1.51 ± 1.79* |
Lymphocytes | 2.8 ± 2.0 | 2.7 ± 1.5 | 2.6 ± 2.1 |
Eosinophils | 0.14 ± 0.17* | 0.23 ± 0.26* | 0.37 ± 0.49* |
BAL, % | |||
Macrophages | 83.1 ± 6.8 | 80.9 ± 8.8 | 80.2 ± 10.3 |
Neutrophils | 2.6 ± 2.3* | 4.5 ± 4.1* | 6.4 ± 5.9* |
Lymphocytes | 13.6 ± 6.9 | 13.6 ± 7.9 | 11.8 ± 5.5 |
Eosinophils | 0.7 ± 0.8* | 1.1 ± 1.0* | 1.5 ± 1.6* |
Cells, ×104 cells/ml | |||
Epithelial | 0.98 ± 1.21 | 0.74 ± 0.93 | 0.88 ± 1.06 |
Squamous | 0.33 ± 0.26 | 0.18 ± 0.18 | 0.26 ± 0.28 |
Red blood | 10.3 ± 10.0 | 8.0 ± 8.2 | 19.7 ± 39.8 |
Total protein, μg/ml | 69.0 [38.0, 86.0]* | 69.6 [42.3, 96.9]* | 100.4 [70.4, 157.8]* |
IL, pg/ml | |||
IL-1b | 0.13 [0.13, 0.13] | 0.13 [0.13, 0.13] | 0.13 [0.13, 0.13] |
IL-5 | 0.04 [0.03, 0.13] | 0.08 [0.03, 0.30] | 0.12 [0.03, 0.23] |
IL-6 | 1.45 [0.40, 2.08]* | 2.47 [0.27, 5.25]* | 3.66 [0.91, 8.04]* |
IL-7 | 0.39 [0.13, 0.57] | 0.81 [0.26, 1.14] | 0.57 [0.43, 1.54] |
IL-8 | 5.75 [0.94, 9.33]* | 10.11 [7.81, 21.12]* | 11.35 [8.10, 17.76]* |
IL-12 | 0.13 [0.13, 0.13] | 0.13 [0.13, 0.13] | 0.13 [0.13, 0.13] |
IFN-γ, pg/ml | 0.64 [0.64, 0.64] | 0.64 [0.64, 0.64] | 0.64 [0.64, 0.64] |
Granulocyte macrophage colony-stimulating factor, pg/ml | 1.16 [0.81, 2.95] | 1.86 [0.93, 3.2] | 3.04 [1.74, 4.09] |
TNF-α, pg/ml | 0.16 [0.07, 0.37] | 0.19 [0.07, 0.58] | 0.37 [0.14, 0.74] |
Values are means ± SD and median [interquartile range]. BAL, bronchoalveolar lavage.
Values represent changes that were significant with increasing level of ozone exposure by regression analysis.